Introduction {#sec1}
============

Embryonic cardiogenesis is a complex process controlled by an intricate regulatory network that involves several cardiac-specific genes, including cardiac transcription factors in the GATA, Mef2, Tbx, and Nkx2 families.[@bib1], [@bib2] GATA4, a zinc finger protein is among these special transcription factors, and serves as a potent driver of cardiogenesis from the early stages of the embryonic heart to birth.[@bib3], [@bib4] A link has been reported between several human congenital heart diseases and heterozygous mutations in the *gata4* gene.[@bib2], [@bib5] Additionally, GATA4 is essential for the formation of the proepicardium.[@bib6] Thus, its precise spatial and temporal expression is necessary for normal embryonic cardiogenesis. However, despite these important findings, the molecular basis underlying the time-dependent activation of *gata4* gene expression during cardiogenesis remains largely unexplored.

It is well known that epigenetic modification, such as histone acetylation, can modulate gene expression patterns, further influencing the development of embryonic organs. Histone acetyltransferases (HATs) acetylate the N-terminal tails of the lysine residues on histones and facilitate the opening of chromatin spatial structures, resulting in the activation of transcription.[@bib7], [@bib8], [@bib9] The experimental hyper-acetylation of target gene histones results in the precocious differentiation of cardiac progenitor cells and cardiac developmental defects.[@bib10] Histone acetylation inhibitors can correct the over-expression of pathological cardiac genes that is due to alcohol exposure during pregnancy.[@bib11] The E1A-associated 300kD protein (P300) is one of the intrinsic HATs that can modulate embryonic development. In human neural differentiation, P300 can take part in the expression of neurodevelopmental genes through regulating H3K9ac.[@bib12] In the cardiac transcription network, P300 can facilitate the activation of target genes through the acetylation of the lysine residues of histones in the promoters of the target gene.[@bib13] Our previous research revealed that the hypo-acetylation induced by the P300 inhibitor represses *gata4* expression in cardiocytes.[@bib14] These studies remind us that P300 may participate in embryonic *gata4* expression.

Here, we sought to investigate the potential role of P300-mediated histone acetylation in *gata4* transcription. We have demonstrated the time-course of *gata4* in embryonic murine hearts using RT-qPCR. We also examined the enrichment of histone acetylation markers in *gata4* promoters by taking advantage of chromatin immunoprecipitation coupled with quantitative PCR (ChIP-qPCR). Then we further confirmed our findings by selectively inhibiting the acetylation function of P300 and studying its role in *gata4* transcription through P300 knockdown experiments in cardiac progenitor cells. Thus, we believe our study has proven that P300-mediated acetylation of histone H3K4, H3K9, and H3K27 served as an essential driver in the regulation of *gata4* expression in cardiac progenitor cells, and have herein provided evidence for future investigations of epigenetic regulation in embryonic cardiogenesis.

Materials and methods {#sec2}
=====================

Collection of embryonic mouse hearts {#sec2.1}
------------------------------------

Adult Kunming mice were obtained from the Laboratory Animal Center of Chongqing Medical University (Chongqing, China). The mice were housed in an environment with a stable temperature of 22.2 °C and had free access to normal water and food. Embryo day 0.5 (E0.5) was defined as the morning when conception plugs were found after cohabitation. The hearts of embryos between stages E 11.5 to postnatal day 1 (P1) were collected every day for further experiments.

Cell lines {#sec2.2}
----------

Cardiac progenitor cells were kindly provided by the Molecular Oncology Laboratory of the University of Chicago Medical Center (Illinois, USA)[@bib15] and cultured in DMEM/F12 (Gibco, China) containing 10% fetal bovine serum (Gibco, Australia) and penicillin/streptomycin. The cells were incubated at 37 °C in a humidified atmosphere of 5% CO2. Lentivirus containing three target P300 siRNAs were obtained from HANBIO (Shanghai, China). The target sequence was as follows: 5′- GGAACTACCCTAC TTTGAAGG -3′. Transfection was performed according to the manufacturer\'s instructions. In the inhibitor experiment, SGC-CBP30 (Selleck, Shanghai, China) was added at a concentration of 2 μM for 6 h prior to RT-qPCR and Chromatin immunoprecipitation.

Flow cytometry {#sec2.3}
--------------

After 48 h of interference, cardiac progenitor cells were digested with 0.25% trypsin (Solarbio, Beijing, China) and made into single-cell suspensions in a 2M phosphate buffer solution. Cells were assayed with a flow cytometer (Becton Dickinson, USA). Data were collected and analyzed using FACSDiva software, version 6.1.2 (Becton Dickinson). The percentage of green fluorescence protein (GFP) represented the efficiency of lentiviral transfection.

RT-qPCR {#sec2.4}
-------

We extracted total RNA using Trizol (Ambion, CA, USA), and reverse-transcribed cDNA using the PrimeScript RT reagent kit (Takara, Beijing, China), according to the manufacturer\'s instructions. Then, we amplified and quantified cDNA using the KAPA SYBR FAST qPCR KITS (Cape Town, South Africa) with a CFX96 Touch Real-Time PCR Detection System (Bio-Rad, CA, USA). The primer sequences used in our experiments were as follows: *gata4* (F) 5′- CCCTCCCGCACGATTTCT-3′, (R) 5′- AGAGGCCCAACTCGCTCAA -3′; *p300* (F) 5′- GCCCTGGATTAAGTTTGA-3′, (R) 5′- TGAGTAGGACCCTGATTTG -3′; *tbx5* (F) 5′-CCAAAGACAGGTCTTGCGATTCG -3′, (R) 5′- TTCTCCTCCCTGCCTTGGTGAT -3′; *gapdh* (F) 5′- GGCATCTTGGGCTACAC -3′, (R) 5′- TACCAGGAAATGAGCTTGA -3′. Each transcript was quantified in triplicate and the expression levels of the target genes were normalized to the control gene (GAPDH) using the △△CT method.

Chromatin immunoprecipitation (ChIP) {#sec2.5}
------------------------------------

ChIP assays were performed using the Chromatin Extraction kit (Abcam, Cambridge, England) and ChIP kit (Abcam, Cambridge, England), according to the manufacturer\'s instructions. The antibodies used in the assays were the following: anti-P300 antibody, anti-CBP antibody, anti-PCAF antibody, anti-GCN5 antibody, anti-Histone H3 acetyl antibody, anti-Histone H3 (acetyl K4) antibody, anti-Histone H3 (acetyl K9) antibody, and anti-Histone H3 (acetyl K27) antibody (Abcam, Cambridge, England). The level of immunoprecipitated DNA was measured by qRT-PCR using a KAPA SYBR FAST qPCR kit (Cape Town, South Africa). The primer sequences for ChIP-Q-PCR were; *gata4* (F) 5′- CACTGACGCCGACTCCAAACTAA-3′, (R) 5′- CGACTGGGGTCCAATCAAAAGG -3′, and *tbx5* (F) 5′-TCTAAGCCGTTCTGGAGCCC GACA-3′, (R) 5′-AGAGCCTCCCAGCGACTG CCCAC-3′. Then the ChIP DNA Ct values were normalized to the input (the total DNA collected after release) using the △△CT method.

Statistical analysis {#sec2.6}
--------------------

All results were presented as mean ± SE for at least three independent experiments using SPSS 17.0 software (Chicago, Illinois, USA). Two-tailed Student\'s t test was used to evaluate statistical significance between two groups, and one-way ANOVA was used among multiple groups. A p-value \<0.05 was considered to be statistically significant.

Results {#sec3}
=======

Cardiac *gata4* is expressed in a time-course manner in mouse embryos {#sec3.1}
---------------------------------------------------------------------

In embryonic cardiogenesis, GATA4 serves as an essential transcription factor that can regulate the expression of structural and functional cardiac genes, which are expressed in a dynamic manner during the process.[@bib16] Because of GATA4\'s participation in the transcription pathway of these important cardiac genes, we set out to investigate the time-course of *gata4* expression in embryonic cardiogenesis. We collected the hearts of normal Kunming mice at E11.5 (Embryonic day 11.5) to P1 (postnatal day 1). We then used RT-qPCR to detect *gata4* mRNA in embryonic and newborn hearts. We found that there was a significant increase of *gata4* mRNA at E14.5 compared to E11.5, and after that point levels remained relatively stable until birth ([Fig. 1](#fig1){ref-type="fig"}A). We thus believed that *gata4* was expressed in a time-course manner in mouse embryos, and that E14.5 was a special time in the process.Figure 1**Dynamic expression of GATA4 in embryonic and newborn mouse hearts.** RT-qPCR demonstrates a significant increase in GATA4 mRNA at E14.5 compared with E11.5, and GATA4 mRNA remain relatively stable until birth. The mRNA expression of GATA4 has been normalized to that of GAPDH. Data are represented as mean ± SD from three independent experiments. \*P \< 0.05, as compared with E11.5.Fig. 1

Histone acetylation regulates *gata4* expression in the embryonic heart {#sec3.2}
-----------------------------------------------------------------------

We have previously shown that histone hypoacetylation represses *gata4* expression in cardiocytes.[@bib14] In this study, we wanted to investigate the molecular mechanism involved in the regulation of the *gata4* expression time-course in embryonic mouse hearts. First, we performed ChIP analysis using antibodies against histone acetylases (P300, CBP, GCG5, and PCAF), and histone deacetylases (HDAC4, HDAC5, and HDAC9), followed by qPCR using primers targeting the *gata4* promoters in different stages of the embryonic mouse hearts. As shown in [Fig. 2](#fig2){ref-type="fig"}A, we detected a significantly higher abundance of both P300 and CBP at E14.5 compared to E11.5. Simultaneously, we found that the level of GCN5 binding was stable along the course of embryonic development, and that there was a significant decrease in PCAF occupancy of the *gata4* promoters at E14.5, indicating that P300 and CBP, but not GCN5 and PCAF, might participate in the physiological *gata4* increase. As for the HDACs, our findings revealed that HDAC4, HDAC5, and HDAC9 bound less to *gata4* promoters at E 14.5 when compared with E11.5 ([Fig. 2](#fig2){ref-type="fig"}B). These data suggested that there was a positive correlation between the higher expression of *gata4* and the histone acetylation mediated by P300 and CBP, rather than GCG5 and PCAF, and also a negative correlation to HDAC4, HDAC5, and HDAC9.Figure 2**Histone acetylation near the GATA4 promoter in embryonic mouse hearts.** ChIP-qPCR demonstrates that (A) Enrichment of p300 and CBP in the GATA4 promoter was highest at E14.5, while GCN5 was stable in the process and PCAF decreased at E14.5. (B) Enrichment of HDACs in the GATA4 promoter decreased significantly at E14.5. (C) Abundance of H3ac, H3K4ac, H3K9ac, and H3K27ac in the GATA4 promoter increased significantly at E14.5. In these graphs, relative enrichment represents the average fold enrichment of GATA4 promoter vs. input. Data are represented as mean ± SD from three independent experiments. \*P \< 0.05, as compared with neighboring groups.Fig. 2

After finding that histone acetylation regulated *gata4* expression in the embryonic heart, we decided to concentrate on revealing how histone acetylation regulates *gata4* in cardiac development. To explore the acetylation of different histone lysines in the *gata4* promoters, ChIP was performed using antibodies against H3ac, H3K4ac, H3K9ac, and H3K27ac, followed by qPCR using primers targeting the *gata4* promoters in E11.5, E14.5, and E17.5 embryonic mouse hearts. Our results showed that the global acetylation of H3 in *gata4* promoters was highest at E14.5. Additionally, the acetylation of H3K4 increased significantly at E14.5 and remained stable until birth, a trend that was similarly seen in the expression of *gata4* mRNA. We also observed sustainable growth of H3K9 acetylation. Meanwhile, acetylation of H3K27 exhibited a similar trend to that of global H3 acetylation in *gata4* promoters ([Fig. 2](#fig2){ref-type="fig"}C). These data indicated that, in *gata4* promoters, the acetylation of H3, H3K4, H3K9, and H3K27 could play a role in regulating its transcription.

Transcription of *gata4* expression in cells is closely related to P300 {#sec3.3}
-----------------------------------------------------------------------

To verify the essential role that P300 plays in *gata4* expression in cardiogenesis, we down-regulated P300 in cardiac progenitor cells in vitro. The cardiac progenitor cell lines were a gift from Dr. Mi Li (University of Chicago Medical Center, USA).[@bib15] We infected the cardiac progenitor cells with lentivirus containing P300 siRNAs for more than 48 h. A control group was established by infecting lentivirus containing blank vehicle. The expression of green fluorescent protein (GFP) served as a lentiviral marker, measured by a fluorescence microscope. As shown in [Fig. 3](#fig3){ref-type="fig"}A, cells in both the control group and the P300 siRNA group expressed GFP. Next, we used flow cytometry to detect the lentiviral infection efficiency. As shown in [Fig. 3](#fig3){ref-type="fig"}B, transfection efficiencies in the control group and the P300 siRNA group were 62.3% and 73.7%, respectively. Additionally, we detected the expression of P300 mRNA using RT-qPCR. As shown in [Fig. 3](#fig3){ref-type="fig"}C, P300 siRNA yielded an obvious inhibition of P300 expression, suggesting efficient interference of P300. We then assessed the relative mRNA levels of *gata4* in cardiac progenitor cells. Tbx5 was chosen as control gene. Results from RT-qPCR demonstrated a significant decrease in the expression of *gata4* in the P300 siRNA group, as compared to that in control group ([Fig. 3](#fig3){ref-type="fig"}D). At the same time, there was no obvious change in Tbx5 mRNA. This indicated that a down-regulation of P300 could result in decreased *gata4* transcription.Figure 3**Downregulating p300 decreases GATA4 expression through histone hypo-acetylation.** (A) Fluorescence microscopy was used to measure expression of green fluorescent protein (GFP) as a lentiviral marker (green). (B) FCM demonstrated that the transfection efficiencies of lentivirus in the control and P300 siRNA groups were 62.3% and 73.7%, respectively. (C--D) RT-qPCR analysis shows that p300 siRNA inhibited the expression of p300 by more than 50%. Interference of p300 resulted in an obvious decrease in GATA4 but no change in Tbx5. The mRNA expression of GATA4 has been normalized to that of GAPDH. (E--G) ChIP-qPCR revealed that the acetylation state of total H3, H3K4, H3K9, and H3K27 next to the GATA4 promoter was inhibited after p300 interference. Significant suppression of p300 in GATA4 promoter was detected in the p300 siRNA group, while more CBP and PCAF bound to the GATA4 promoter. Enrichment of H3ac, H3K4ac, and H3K27ac in Tbx5 promoters is suppressed due to the lack of p300, with the exception of H3K9ac. Relative enrichment represents the average fold enrichment of GATA4 or Tbx5 promoter vs. input. Data are represented as mean ± SD from three independent experiments. \*P \< 0.05, as compared with the control group. ^\#^P \> 0.05, as compared with the control group.Fig. 3

P300 is a broad-spectrum histone acetylase. To narrow down which P300-mediated lysine acetylation takes part in *gata4* transcription, we performed ChIP using antibodies against H3ac, H3K4ac, H3K9ac, and H3K27ac, followed by qPCR using primers targeting *gata4* promoters in order to detect the acetylation state of histones in the *gata4* promoters. As shown in [Fig. 3](#fig3){ref-type="fig"}E, the acetylation of global H3, H3K4, H3K9, and H3K27 in the *gata4* promoters was inhibited after P300 interference. Simultaneously, the level of P300 binding in the *gata4* promoters decreased after P300 mRNA was suppressed, while more CBP and PCAF bound to the *gata4* promoters ([Fig. 3](#fig3){ref-type="fig"}F). This result suggested that suppression of P300 binding to the *gata4* promoters influenced the transcription of *gata4*, rather than CBP and PCAF. On the other hand, enrichment of H3ac, H3K4ac, and H3K27ac in the Tbx5 promoters was suppressed due to the lack of P300, except for H3K9ac ([Fig. 3](#fig3){ref-type="fig"}G). Although P300 takes part in the H3K4ac and H3K27ac of histone in Tbx5 promoters, it cannot regulate Tbx5 transcription. We therefore concluded that this data could demonstrate that P300 has an essential role in *gata4* transcription through modulating the acetylation of histone H3K4, H3K9, and H3K27 in *gata4* promoters.

Bromodomain inhibitor CBP30 can decrease *gata4* transcription through repression of P300 binding to *gata4* promoters regions {#sec3.4}
------------------------------------------------------------------------------------------------------------------------------

The P300 protein contains a bromodomain and a lysine acetyltransferase domain, which are involved in acetylation modification. After bromodomain recognizes acetyl-lysine in histones and non-histone proteins, the lysine acetyltransferase domain transfers an acetyl group from acetyl co-enzyme A to unmodified lysine residues.[@bib17], [@bib18] To reinforce the P300-mediated histone acetylation that modulates *gata4* transcription, we introduced CBP30, a selective CBP/P300 bromodomain inhibitor, to repress the acetyltransferase function of P300.[@bib19], [@bib20] The cardiac progenitor cells were treated with 2 μM CBP30 while the same volume of DMSO was added to the culture medium of the control group. After 48 h, cells treated with CBP30 showed no obvious signs of toxicity (based on mortality and proliferation). Results from RT-qPCR demonstrated that after normalization to GAPDH, the level of *gata4* mRNA was suppressed by CBP30 ([Fig. 4](#fig4){ref-type="fig"}A). We then performed ChIP-qPCR in order to detect the abundance of HATs to *gata4* promoters. As shown in [Fig. 4](#fig4){ref-type="fig"}B, we observed a significant suppression of P300 and CBP binding to *gata4* promoters following CBP30 treatment, whereas the enrichment of PCAF and GCN5 in *gata4* promoters remained unchanged. This indicated that CBP30 could effectively and selectively repress enrichment of P300 and CBP in *gata4* promoters, which is consistent with what Hammitzsch et al observed in human T cells.[@bib21] In order to identify the specific lysine residues in the *gata4* promoters whose acetylation is important in *gata4* transcription, we performed ChIP-qPCR to detect the acetylation state of H3K4, H3K9, and H3K27 in *gata4* promoters. As shown in [Fig. 4](#fig4){ref-type="fig"}C, the enrichment of H3K4ac, H3K9ac, and H3K27ac in *gata4* promoters was inhibited following CBP30 treatment. These data reinforced our hypothesis that P300-mediated acetylation of histone H3K4, H3K9, and H3K27 serves as an essential mechanism in the regulation of *gata4* expression in cardiac progenitor cells.Figure 4**The p300 bromodomain inhibitor CBP30 decreases GATA4 transcription through histone acetylation.** (A) RT-qPCR analysis shows that CBP30 suppressed GATA4 mRNA. The mRNA expression of GATA4 has been normalized to that of GAPDH. (B--C) ChIP-qPCR analysis indicates a significant suppression of p300 and CBP binding to GATA4 promoters in the CBP30 group as compared to the DMSO group, while the enrichment of PCAF and GCN5 was unchanged. The enrichment of H3K4ac, H3K9ac, and H3K27ac in the GATA4 promoters was inhibited after CBP30 treatment. Relative enrichment represents the average fold enrichment of the GATA4 promoter vs. input. Data are represented as mean ± SD from three independent experiments. \*P \< 0.05, as compared to the blank and DMSO groups. ^\#^P \> 0.05, as compared to the blank and DMSO groups.Fig. 4

Discussion {#sec4}
==========

Embryonic cardiogenesis is an intricate process that is modulated by several cardiac transcription factors, such as those in the GATA, Mef2, Tbx, and Nkx2 families. GATA4 is an important cardiac transcription factor and tends to regulate the expression of numerous cardiac structural and functional genes in cardiogenesis.[@bib22], [@bib23], [@bib24] The existence of *gata4* mutations has been proven in plenty of patients with congenital heart disease.[@bib2], [@bib25], [@bib26] Deficiency of *gata4* results in hearts defects such as common atrioventricular canal (CAVC), double outlet right ventricle (DORV), and hypoplastic ventricular myocardium.[@bib27] However, several genes and environmental factors regulate spatial and temporal expression of *gata4*.[@bib28] We found that *gata4* was expressed in a time-course manner in embryonic mouse hearts, gradually increasing from embryonic age E11.5 to E14.5, and then remaining constant until birth. Although these findings highlight the potential importance of *gata4* regulation, the molecular basis underlying *gata4* gene expression during cardiogenesis remains largely unexplored.

Recent research has discovered that histone acetylation can activate gene expression and further influence the development of embryonic organs.[@bib29], [@bib30], [@bib31] HATs can facilitate transcription by acetylating the N-terminal tails of lysine residues of histones in promoters to open chromatin spatial structures.[@bib7], [@bib8], [@bib9] The four HATs reported to be closely involved in cardiogenesis are P300, CBP, GCN5, and PCAF. Our previous research revealed that the hypo-acetylation caused by inhibition of P300 could repress *gata4* expression in cardiocytes.[@bib14] In this study, we found that it was the histone acetylation mediated by P300 and CBP that influenced *gata4* expression, but not acetylation mediated by GCG5 and PCAF. Using P300 knockdown cardiac progenitor cells, we revealed that P300 is necessary for *gata4* transcription, whereas a lack of P300 does not influence the other transcriptional factor Tbx5 mRNA expression.

Among different cell populations, the effects of acetylation of different lysine residues in histone could be quite distinct. H3K9ac plays a dual role in human embryonic stem cell pluripotency and neural differentiation.[@bib12] In retinal cells, inhibition of histone deacetylase 1 (hdac1) results in an increase of h3k9ac but not h3k27ac, and leads to rod photoreceptor differentiation.[@bib32] To determine the acetylation of which lysines takes part in *gata4* transcription, we further demonstrated the enrichment of H3K4ac, H3K9ac, and H3K27ac in *gata4* promoters. We found that acetylation of H3, H3K4, H3K9, and H3K27 in *gata4* promoters may play a role in regulating its transcription. On the other hand, although P300 takes part in H3K4ac and H3K27ac of histone in Tbx5 promoters, it cannot regulate Tbx5 transcription.

SGC-CBP30 is a selective CBP/P300 bromodomain inhibitor, which can prevent bromodomain recognizing acetyl-lysine in histones, blocking the lysine acetyltransferase domain\'s transfer of an acetyl group from acetyl co-enzyme A to unmodified lysine residues.[@bib33] To explore the histone acetylation function of P300 that is responsible for modulation of *gata4* transcription, we introduced SGC-CBP30 in order to repress the acetyltransferase activity of P300. We were able to reinforce our hypothesis that P300-mediated acetylation of histone H3K4, H3K9, and H3K27 serve as an essential mechanism in the regulation of *gata4* expression in cardiac progenitor cells.

In conclusion, our observations reported that P300-mediated acetylation of H3K4, H3K9, and H3K27 regulated the expression of *gata4* in cardiomyocytes. Our results represent a further advancement in the molecular dissection of the regulatory mechanisms controlling embryonic cardiogenesis. These findings will be to the benefit of the effort to reduce the incidence of congenital heart disease.

Conflicts of interest {#sec5}
=====================

The authors have no conflict of interests to declare.

Appendix A. Supplementary data {#appsec1}
==============================

The following is the Supplementary data to this article:Multimedia component 1Multimedia component 1

The study was supported by research grants from the National Natural Science Foundation of China (Grant Number: 81300129).

Peer review under responsibility of Chongqing Medical University.

Supplementary data to this article can be found online at <https://doi.org/10.1016/j.gendis.2018.10.002>.
